Cardiometabolic aspects of polycystic ovarian syndrome

References

• AhimaRSFlierJSAdipose tissue as an endocrine organTrends Endocrinol Metab2000113273210996528
   PubMed Web of Science ®Google Scholar
• AjossaSGuerrieroSPaolettiAMThe treatment of polycystic ovary syndromeMinerva Ginecol200456152614973407
   PubMedGoogle Scholar
• AlbertiKGZimmetPShawJMetabolic syndrome–a new world-wide definition. A Consensus Statement from the International Diabetes FederationDiabet Med2006234698016681555
   PubMed Web of Science ®Google Scholar
• AlbertiKGZimmetPZDefinition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultationDiabet Med199815539539686693
   PubMed Web of Science ®Google Scholar
• AndersonPJCritchleyJAChanJCFactor analysis of the metabolic syndrome: obesity vs insulin resistance as the central abnormalityInt J Obes Relat Metab Disord2001251782811781758
   PubMed Web of Science ®Google Scholar
• AndersenPSeljeflotIAbdelnoorMIncreased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndromeMetabolism199544611167752909
   PubMed Web of Science ®Google Scholar
• ArnerPHuman fat cell lipolysis: biochemistry, regulation and clinical roleBest Pract Res Clin Endocrinol Metab2005194718216311212
   PubMed Web of Science ®Google Scholar
• AsuncionMCalvoRMSan MillanJLA prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from SpainJ Clin Endocrinol Metab2000852434810902790
   PubMed Web of Science ®Google Scholar
• AtiomoWUBatesSACondonJEThe plasminogen activator system in women with polycystic ovary syndromeFertil Steril199869236419496335
   PubMed Web of Science ®Google Scholar
• AtiomoWUFoxRCondonJERaised plasminogen activator inhibitor-1 (PAI-1) is not an independent risk factor in the polycystic ovary syndrome (PCOS)Clin Endocrinol (Oxf)2000524879210762292
   PubMed Web of Science ®Google Scholar
• AzzizRWoodsKSReynaRThe prevalence and features of the polycystic ovary syndrome in an unselected populationJ Clin Endocrinol Metab2004892745915181052
   PubMed Web of Science ®Google Scholar
• BahceciMTuzcuACanorucNSerum C-reactive protein (CRP) levels and insulin resistance in non-obese women with polycystic ovarian syndrome, and effect of bicalutamide on hirsutism, CRP levels and insulin resistanceHorm Res200462283715542929
   PubMed Web of Science ®Google Scholar
• BalenAHConwayGSKaltsasGPolycystic ovary syndrome: the spectrum of the disorder in 1741 patientsHum Reprod1995102107118567849
   PubMed Web of Science ®Google Scholar
• BalenAHLavenJSTanSLUltrasound assessment of the polycystic ovary:international consensus definitionsHum Reprod Update200395051414714587
   PubMed Web of Science ®Google Scholar
• BasdevantARaisonJGuy-GrandB[Influence of the distribution of body fat on vascular risk]Presse Med198716167702950448
   PubMed Web of Science ®Google Scholar
• BhagatKVallancePEffects of cytokines on nitric oxide pathways in human vasculatureCurr Opin Nephrol Hypertens1999889969914865
   PubMed Web of Science ®Google Scholar
• BickertonASClarkNMeekingDCardiovascular risk in women with polycystic ovarian syndrome (PCOS)J Clin Pathol200558151415677534
   PubMed Web of Science ®Google Scholar
• BirdsallMAFarquharCMWhiteHDAssociation between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterizationAnn Intern Med19971263258992921
   PubMed Web of Science ®Google Scholar
• BitarMSWahidSMustafaSNitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetesEur J Pharmacol2005511536415777779
   PubMed Web of Science ®Google Scholar
• BrettenthalerNDe GeyterCHuberPREffect of the insulin sensitizer pioglitazone on insulin resistance, hyperandrogenism, and ovulatory dysfunction in women with polycystic ovary syndromeJ Clin Endocrinol Metab20048938354015292314
   PubMed Web of Science ®Google Scholar
• CalvarCEIntebiADBengoleaSV[Leptin in patients with polycystic ovary syndrome. Direct correlation with insulin resistance]Medicina (B Aires)2003637041014719312
   PubMed Web of Science ®Google Scholar
• CarminaEKoyamaTChangLDoes ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?Am J Obstet Gynecol19921671807121471702
   PubMed Web of Science ®Google Scholar
• CarminaEOrioFPalombaSEvidence for altered adipocyte function in polycystic ovary syndromeEur J Endocrinol20051523899415757855
   PubMed Web of Science ®Google Scholar
• CarminaEOrioFPalombaSEndothelial dysfunction in PCOS: role of obesity and adipose hormonesAm J Med2006119356 e1616564785
   PubMed Web of Science ®Google Scholar
• CarrDBUtzschneiderKMHullRLIntra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndromeDiabetes20045320879415277390
   PubMed Web of Science ®Google Scholar
• CataldoNAAbbasiFMcLaughlinTLMetabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndromeHum Reprod2006211092016155076
   PubMed Web of Science ®Google Scholar
• CelermajerDSSorensenKEGoochVMNon-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosisLancet19923401111151359209
   PubMed Web of Science ®Google Scholar
• CeliFSShuldinerARThe role of peroxisome proliferator-activated receptor gamma in diabetes and obesityCurr Diab Rep200221798512643137
   PubMedGoogle Scholar
• ChenYDSheuWHSwislockiALHigh density lipoprotein turnover in patients with hypertensionHypertension199117386931900259
   PubMed Web of Science ®Google Scholar
• CibulaDCifkovaRFantaMIncreased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndromeHum Reprod200015785910739820
   PubMed Web of Science ®Google Scholar
• ConwayGSAgrawalRBetteridgeDJRisk factors for coronary artery disease in lean and obese women with the polycystic ovary syndromeClin Endocrinol (Oxf)199237119251395062
   PubMed Web of Science ®Google Scholar
• CrosignaniPGColomboMVegettiWOverweight and obese anovulatory patients with polycystic ovaries:parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by dietHum Reprod20031819283212923151
   PubMed Web of Science ®Google Scholar
• DahlgrenEJansonPOJohanssonSHemostatic and metabolic variables in women with polycystic ovary syndromeFertil Steril199461455608137966
   PubMed Web of Science ®Google Scholar
• Diamanti-KandarakisEKouliCRBergieleATA survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profileJ Clin Endocrinol Metab19998440061110566641
   PubMed Web of Science ®Google Scholar
• DietschyJMBrownMSEffect of alterations of the specific activity of the intracellular acetyl CoA pool on apparent rates of hepatic cholesterogenesisJ Lipid Res197415508164413018
   PubMed Web of Science ®Google Scholar
• DunaifAHyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitusAm J Med19959833S39S7825639
   PubMed Web of Science ®Google Scholar
• DunaifAFinegoodDTBeta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndromeJ Clin Endocrinol Metab19968194278772555
   PubMed Web of Science ®Google Scholar
• EhrmannDABarnesRBRosenfieldRLPrevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndromeDiabetes Care199922141610333916
   PubMed Web of Science ®Google Scholar
• EhrmannDASchneiderDJSobelBETroglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndromeJ Clin Endocrinol Metab1997822108169215280
   PubMed Web of Science ®Google Scholar
• EhrmannDASturisJByrneMMInsulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitusJ Clin Invest19959652077615824
   PubMed Web of Science ®Google Scholar
• EltingMWKorsenTJBezemerPDPrevalence of diabetes mellitus, hypertension and cardiac complaints in a follow-up study of a Dutch PCOS populationHum Reprod2001165566011228228
   PubMed Web of Science ®Google Scholar
• EngeliSSchlingPGorzelniakKThe adipose-tissue renin-angiotensin-aldosterone system:role in the metabolic syndrome?Int J Biochem Cell Biol2003358072512676168
   PubMed Web of Science ®Google Scholar
• ESHRE/ASRM-Sponsored_PCOS_Consensus_Workshop_GroupRevised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndromeFertil Steril2004811925
   Web of Science ®Google Scholar
• FogelRBMalhotraAPillarGIncreased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndromeJ Clin Endocrinol Metab20018611758011238505
   PubMed Web of Science ®Google Scholar
• FranksSPolycystic ovary syndromeN Engl J Med1995333853617651477
   PubMed Web of Science ®Google Scholar
• FriedmanJMHalaasJLLeptin and the regulation of body weight in mammalsNature1998395763709796811
   PubMed Web of Science ®Google Scholar
• FruhbeckGThe adipose tissue as a source of vasoactive factorsCurr Med Chem Cardiovasc Hematol Agents2004219720815320786
   PubMedGoogle Scholar
• FruhbeckGGomez-AmbrosiJModulation of the leptininduced white adipose tissue lipolysis by nitric oxideCell Signal2001138273311583918
   PubMed Web of Science ®Google Scholar
• GlueckCJPapannaRWangPIncidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndromeMetabolism2003529081512870169
   PubMed Web of Science ®Google Scholar
• GonzalezFThusuKAbdel-RahmanEElevated serum levels of tumor necrosis factor alpha in normal-weight women with polycystic ovary syndromeMetabolism1999484374110206434
   PubMed Web of Science ®Google Scholar
• GopalMDuntleySUhlesMThe role of obesity in the increased prevalence of obstructive sleep apnea syndrome in patients with polycystic ovarian syndromeSleep Med20023401414592171
   PubMedGoogle Scholar
• GrundySMBrewerHBJrCleemanJIDefinition of metabolic syndrome:Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definitionCirculation2004109433814744958
   PubMed Web of Science ®Google Scholar
• GuzickDSTalbottEOSutton-TyrrellKCarotid atherosclerosis in women with polycystic ovary syndrome:initial results from a case-con-trol studyAm J Obstet Gynecol199617412249 discussion 1229–328623850
   PubMed Web of Science ®Google Scholar
• HarborneLFlemingRLyallHMetformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndromeJ Clin Endocrinol Metab20038841162312970273
   PubMed Web of Science ®Google Scholar
• HolteJDisturbances in insulin secretion and sensitivity in women with the polycystic ovary syndromeBaillieres Clin Endocrinol Metab199610221478773746
   PubMed Web of Science ®Google Scholar
• HolteJBerghTBerneCSerum lipoprotein lipid profile in women with the polycystic ovary syndrome:relation to anthropometric, endocrine and metabolic variablesClin Endocrinol (Oxf)199441463717955457
   PubMed Web of Science ®Google Scholar
• HolteJGennarelliGBerneCElevated ambulatory day-time blood pressure in women with polycystic ovary syndrome: a sign of a pre-hypertensive state?Hum Reprod1996112388671152
   PubMed Web of Science ®Google Scholar
• Huber-BuchholzMMCareyDGNormanRJRestoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormoneJ Clin Endocrinol Metab1999841470410199797
   PubMed Web of Science ®Google Scholar
• IbanezLde ZegherFPotauNPremature pubarche, ovarian hyperandrogenism, hyperinsulinism and the polycystic ovary syndrome: from a complex constellation to a simple sequence of prenatal onsetJ Endocrinol Invest199821558669856410
   PubMed Web of Science ®Google Scholar
• IbanezLVallsCMarcosMVInsulin sensitization for girls with precocious pubarche and with risk for polycystic ovary syndrome:effects of prepubertal initiation and postpubertal discontinuation of metformin treatmentJ Clin Endocrinol Metab2004894331715356029
   PubMed Web of Science ®Google Scholar
• JayagopalVKilpatrickESHoldingSOrlistat is as beneficial as metformin in the treatment of polycystic ovarian syndromeJ Clin Endocrinol Metab2005907293315536162
   PubMed Web of Science ®Google Scholar
• KawashimaSYokoyamaMDysfunction of endothelial nitric oxide synthase and atherosclerosisArterioscler Thromb Vasc Biol200424998100515001455
   PubMed Web of Science ®Google Scholar
• KellyCCLyallHPetrieJRLow grade chronic inflammation in women with polycystic ovarian syndromeJ Clin Endocrinol Metab2001862453511397838
   PubMed Web of Science ®Google Scholar
• KentSCLegroRSPolycystic ovary syndrome in adolescentsAdolesc Med2002137388vi11841956
   PubMedGoogle Scholar
• KiddyDSHamilton-FairleyDSeppalaMDiet-induced changes in sex hormone binding globulin and free testosterone in women with normal or polycystic ovaries:correlation with serum insulin and insulin-like growth factor-IClin Endocrinol (Oxf)198931757632697481
   PubMed Web of Science ®Google Scholar
• KnochenhauerESKeyTJKahsar-MillerMPrevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States:a prospective studyJ Clin Endocrinol Metab1998833078829745406
   PubMed Web of Science ®Google Scholar
• LazurovaIDraveckaIKrausVMetformin versus sibutramine in the treatment of hyperinsulinemia in chronically anovulating womenBratisl Lek Listy20041052071015535111
   PubMedGoogle Scholar
• LegroRSBlanchePKraussRMAlterations in low-density lipoprotein and high-density lipoprotein subclasses among Hispanic women with polycystic ovary syndrome:influence of insulin and genetic factorsFertil Steril199972990510593369
   PubMed Web of Science ®Google Scholar
• LegroRSKunselmanARPrevalence and predictors of dyslipidemia in women with polycystic ovary syndromeAm J Med20011116071311755503
   PubMed Web of Science ®Google Scholar
• Lewandowski2005
   Google Scholar
• MahabeerSJialalINormanRJInsulin and C-peptide secretion in non-obese patients with polycystic ovarian diseaseHorm Metab Res19892150262684835
   PubMed Web of Science ®Google Scholar
• MatherKJKwanFCorenblumBHyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesityFertil Steril200073150610632431
   PubMed Web of Science ®Google Scholar
• MeyerCMcGrathBPTeedeHJOverweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular diseaseJ Clin Endocrinol Metab20059057111616046590
   PubMed Web of Science ®Google Scholar
• Mohamed-AliVPinkneyJHCoppackSWAdipose tissue as an endocrine and paracrine organInt J Obes Relat Metab Disord1998221145589877249
   PubMed Web of Science ®Google Scholar
• Muller-WielandDKotzkaJKnebelMetabolic syndrome and hypertension:pathophysiology and molecular basis of insulin resistanceBasic Res Cardiol199893Suppl 213149833175
   PubMedGoogle Scholar
• MunirIYenHWBaruthTResistin stimulation of 17alpha-hy-droxylase activity in ovarian theca cells in vitro:relevance to polycystic ovary syndromeJ Clin Endocrinol Metab2005904852715886251
   PubMed Web of Science ®Google Scholar
• NCEP/ATPIIIExecutive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)JAMA200128524869711368702
   PubMed Web of Science ®Google Scholar
• NestlerJEJakubowiczDJLean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgensJ Clin Endocrinol Metab199782407599398716
   PubMed Web of Science ®Google Scholar
• NestoRWThe relation of insulin resistance syndromes to risk of cardiovascular diseaseRev Cardiovasc Med20034Suppl 6S111814668699
   PubMedGoogle Scholar
• NonogakiKFullerGMFuentesNLInterleukin-6 stimulates hepatic triglyceride secretion in ratsEndocrinology1995136214397720663
   PubMed Web of Science ®Google Scholar
• NormanRJNoakesMWuRImproving reproductive performance in overweight/obese women with effective weight managementHum Reprod Update2004102678015140873
   PubMed Web of Science ®Google Scholar
• O'MearaNMBlackmanJDEhrmannDADefects in beta-cell function in functional ovarian hyperandrogenismJ Clin Endocrinol Metab199376124178496316
   PubMed Web of Science ®Google Scholar
• OrbetzovaMMShigarminovaRGGenchevGGRole of 24-hour monitoring in assessing blood pressure changes in polycystic ovary syndromeFolia Med (Plovdiv)20034521515366662
   PubMedGoogle Scholar
• OrioFJrPalombaSCascellaTImprovement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month studyJ Clin Endocrinol Metab2005906072616118336
   PubMed Web of Science ®Google Scholar
• PanidisDKoliakosGKourtisASerum resistin levels in women with polycystic ovary syndromeFertil Steril200481361614967374
   PubMed Web of Science ®Google Scholar
• ParadisiGSteinbergHOHempflingAPolycystic ovary syndrome is associated with endothelial dysfunctionCirculation200110314101511245645
   PubMed Web of Science ®Google Scholar
• PekalaPKawakamiMVineWStudies of insulin resistance in adipocytes induced by macrophage mediatorJ Exp Med1983157136056833952
   PubMed Web of Science ®Google Scholar
• Potter van LoonBJKluftCRadderJKThe cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistanceMetabolism19934294598345817
   PubMed Web of Science ®Google Scholar
• RatnerREAn update on the Diabetes Prevention ProgramEndocr Pract200612Suppl 120416627375
   PubMedGoogle Scholar
• ReavenGMBanting lecture 1988. Role of insulin resistance in human diseaseDiabetes19883715956073056758
   PubMed Web of Science ®Google Scholar
• ResnickLMCellular calcium and magnesium metabolism in the pathophysiology and treatment of hypertension and related metabolic disordersAm J Med19929311S20S1387762
   PubMed Web of Science ®Google Scholar
• RobinsonSHendersonADGeldingSVDyslipidaemia is associated with insulin resistance in women with polycystic ovariesClin Endocrinol (Oxf)199644277848729522
   PubMed Web of Science ®Google Scholar
• RondinoneCMAdipocyte-derived hormones, cytokines, and mediatorsEndocrine200629819016622295
   PubMed Web of Science ®Google Scholar
• SabuncuTHarmaMNazligulYSibutramine has a positive effect on clinical and metabolic parameters in obese patients with polycystic ovary syndromeFertil Steril200380119920414607575
   PubMed Web of Science ®Google Scholar
• SahinYYirmibesUKelestimurFThe effects of metformin on insulin resistance, clomiphene-induced ovulation and pregnancy rates in women with polycystic ovary syndromeEur J Obstet Gynecol Reprod Biol20041132142015063963
   PubMed Web of Science ®Google Scholar
• SampsonMKongCPatelAAmbulatory blood pressure profiles and plasminogen activator inhibitor (PAI-1) activity in lean women with and without the polycystic ovary syndromeClin Endocrinol (Oxf)19964562398977761
   PubMed Web of Science ®Google Scholar
• SechiLABartoliEMolecular mechanisms of insulin resistance in arterial hypertensionBlood Press Suppl1996147549162438
   PubMedGoogle Scholar
• SeowKMJuanCCWuL YSerum and adipocyte resistin in polycystic ovary syndrome with insulin resistanceHum Reprod200419485314688155
   PubMed Web of Science ®Google Scholar
• SepilianVNagamaniMEffects of rosiglitazone in obese women with polycystic ovary syndrome and severe insulin resistanceJ Clin Endocrinol Metab20059060515483106
   PubMed Web of Science ®Google Scholar
• SilfenMEDenburgMRManiboAMEarly endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS):comparison between nonobese and obese adolescentsJ Clin Endocrinol Metab2003884682814557441
   PubMed Web of Science ®Google Scholar
• SjoholmANystromTEndothelial inflammation in insulin resistanceLancet20053656101215708106
   PubMed Web of Science ®Google Scholar
• SolomonCGHuFBDunaifAMenstrual cycle irregularity and risk for future cardiovascular diseaseJ Clin Endocrinol Metab20028720131711994334
   PubMed Web of Science ®Google Scholar
• SongJShenHLiJHuangZ[Effects of metformin on the plasminogen activator system, endocrine, metabolic profiles in patients with polycystic ovary syndrome and clomiphene resistant cases]Zhonghua Fu Chan Ke Za Zhi20023786911953071
   PubMedGoogle Scholar
• SpiegelmanBMFlierJSAdipogenesis and obesity: rounding out the big pictureCell199687377898898192
   PubMed Web of Science ®Google Scholar
• StephensJMPilchPFThe metabolic regulation and vesicular transport of GLUT4, the major insulin-responsive glucose transporterEndocr Rev199516529468521793
   PubMed Web of Science ®Google Scholar
• SteppanCMBaileySTBhatSThe hormone resistin links obesity to diabetesNature20014093071211201732
   PubMed Web of Science ®Google Scholar
• SwensonTLThe role of the cholesteryl ester transfer protein in lipoprotein. metabolismDiabetes Metab Rev19917139531816999
   PubMed Web of Science ®Google Scholar
• TalbottEOGuzickDSSutton-TyrrellKEvidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged womenArterioscler Thromb Vasc Biol20002024142111073846
   PubMed Web of Science ®Google Scholar
• TarkunICanturkZArslanBCThe plasminogen activator system in young and lean women with polycystic ovary syndromeEndocr J2004514677215516780
   PubMed Web of Science ®Google Scholar
• TiikkainenMHakkinenAMKorsheninnikovaEEffects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetesDiabetes20045321697615277403
   PubMed Web of Science ®Google Scholar
• TolinoAGambardellaVCaccavaleCEvaluation of ovarian functionality after a dietary treatment in obese women with polycystic ovary syndromeEur J Obstet Gynecol Reprod Biol2005119879315734091
   PubMed Web of Science ®Google Scholar
• VelazquezEMMendozaSGWangPMetformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndromeMetabolism19974645479109854
   PubMed Web of Science ®Google Scholar
• VgontzasANLegroRSBixlerEOPolycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness:role of insulin resistanceJ Clin Endocrinol Metab2001865172011158002
   PubMed Web of Science ®Google Scholar
• VrbikovaJCifkovaRJirkovskaACardiovascular risk factors in young Czech females with polycystic ovary syndromeHum Reprod200318980412721172
   PubMedGoogle Scholar
• WaterworthDMBennettSTGharaniNLinkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndromeLancet1997349986909100625
   PubMed Web of Science ®Google Scholar
• WildRAPainterPCCoulsonPBLipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndromeJ Clin Endocrinol Metab198561946514044782
   PubMed Web of Science ®Google Scholar
• WildSPierpointTJacobsHLong-term consequences of polycystic ovary syndrome: results of a 31 year follow-up studyHum Fertil (Camb)2000a310110511844363
   PubMedGoogle Scholar
• WildSPierpointTMcKeiguePCardiovascular disease in women with polycystic ovary syndrome at long-term follow-up:a retrospective cohort studyClin Endocrinol (Oxf)2000b5259560010792339
   PubMed Web of Science ®Google Scholar
• YildirimBSabirNRelation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndromeFertil Steril20037913586412798883
   PubMed Web of Science ®Google Scholar
• YildizBOHaznedarogluICKirazliSGlobal fibrinolytic capacity is decreased in polycystic ovary syndrome, suggesting a prothrombotic stateJ Clin Endocrinol Metab2002873871512161525
   PubMed Web of Science ®Google Scholar
• YuJGJavorschiSHevenerALThe effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjectsDiabetes20025129687412351435
   PubMed Web of Science ®Google Scholar
• YuYHGinsbergHNAdipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissueCirc Res20059610425215920027
   PubMed Web of Science ®Google Scholar
• ZavaroniICoruzziPBoniniLAssociation between salt sensitivity and insulin concentrations in patients with hypertensionAm J Hypertens1995885587576404
   PubMed Web of Science ®Google Scholar
• ZhangLHRodriguezHOhnoSSerine phosphorylation of human P450c17 increases 17,20-lyase activity:implications for adrenarche and the polycystic ovary syndromeProc Natl Acad Sci U S A19959210619237479852
   PubMed Web of Science ®Google Scholar
• ZimmermannSPhillipsRADunaifAPolycystic ovary syndrome: lack of hypertension despite profound insulin resistanceJ Clin Endocrinol Metab199275508131639952
   PubMed Web of Science ®Google Scholar